AnaptysBio, Inc.

AnaptysBio, Inc.verified

ANAB

Price:

$43.3

Market Cap:

$1.20B

AnaptysBio, Inc., a clinical stage biotechnology company, engages in developing therapeutic product candidates for inflammation and immuno-oncology indications. Its products include Imsidolimab, an antibody that inhibits the interleukin-36 receptor (IL-36R) for the treatment of various dermatological inflammatory diseases; Rosnilimab, an anti-PD-1 agonist antibody program designed to augment PD-1 signaling through rosnilimab treatment to suppress T-cell driven human inflammatory diseases; and ANB032, an anti-BTLA modulator antibody applicable to human inflammatory diseases associated with lymphoid and myeloid immune cell dysregulation. The company also focuses on developing various antibody ...[Read more]

Industry

Biotechnology

IPO Date

2017-01-26

Stock Exchange

NASDAQ

Ticker

ANAB

The Enterprise Value as of December 2025 (TTM) for AnaptysBio, Inc. (ANAB) is 1.10B

According to AnaptysBio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.10B. This represents a change of 79.90% compared to the average of 613.53M of the last 4 quarters.

AnaptysBio, Inc. (ANAB) Historical Enterprise Value (quarterly & annually)

How has ANAB Enterprise Value performed in the past?

The mean historical Enterprise Value of AnaptysBio, Inc. over the last ten years is 694.74M. The current 1.10B Enterprise Value has changed 15.79% with respect to the historical average. Over the past ten years (40 quarters), ANAB's Enterprise Value was at its highest in in the March 2018 quarter at 2.42B. The Enterprise Value was at its lowest in in the December 2015 quarter at 193.86M.

Quarterly (TTM)
Annual

Average

694.74M

Median

518.51M

Minimum

193.86M

Maximum

1.93B

AnaptysBio, Inc. (ANAB) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of AnaptysBio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 609.84%

Maximum Annual Enterprise Value = 1.93B

Minimum Annual Increase = -81.55%

Minimum Annual Enterprise Value = 193.86M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024622.16M11.39%
2023558.56M-31.96%
2022820.98M71.59%
2021478.45M42.03%
2020336.88M24.34%
2019270.94M-81.55%
20181.47B-23.74%
20171.93B609.84%
2016271.29M39.94%
2015193.86M-13.21%

AnaptysBio, Inc. (ANAB) Average Enterprise Value

How has ANAB Enterprise Value performed in the past?

The current Enterprise Value of AnaptysBio, Inc. (ANAB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

667.23M

5-year avg

563.41M

10-year avg

694.74M

AnaptysBio, Inc. (ANAB) Enterprise Value vs. Peers

How is ANAB’s Enterprise Value compared to its peers?

AnaptysBio, Inc.’s Enterprise Value is less than Xencor, Inc. (1.46B), greater than Oculis Holding AG (765.17M), greater than Phathom Pharmaceuticals, Inc. (913.24M), greater than Mind Medicine (MindMed) Inc. (919.17M), less than UroGen Pharma Ltd. (1.17B), less than Nurix Therapeutics, Inc. (1.36B), greater than BridgeBio Oncology Therapeutics Inc. (517.22M), less than Kodiak Sciences Inc. (1.30B), less than Dianthus Therapeutics, Inc. (1.56B), greater than Taysha Gene Therapies, Inc. (872.16M),

Build a custom stock screener for AnaptysBio, Inc. (ANAB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AnaptysBio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AnaptysBio, Inc. (ANAB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AnaptysBio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is AnaptysBio, Inc.'s Enterprise Value?

What is the highest Enterprise Value for AnaptysBio, Inc. (ANAB)?

What is the 3-year average Enterprise Value for AnaptysBio, Inc. (ANAB)?

What is the 5-year average Enterprise Value for AnaptysBio, Inc. (ANAB)?

How does the current Enterprise Value for AnaptysBio, Inc. (ANAB) compare to its historical average?